Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Enlightify Inc.
SIC 2870 · Agricultural Chemicals
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Enlightify Inc.
SIC 2870 · Agricultural Chemicals
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Enlightify Inc.
SIC 2870 · Agricultural Chemicals
Support
about
terms
Enlightify Inc.
CIK:
0000857949
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.25.3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sales
Net sales
$ 14,460,511
$ 17,364,939
Cost of goods sold
Cost of goods sold
11,004,579
13,378,369
Gross profit
3,455,932
3,986,570
Operating expenses
Selling expenses
1,054,106
1,924,428
General and administrative expenses
1,214,227
3,826,904
Change in fair value of Bitcoin
262
Total operating expenses
2,268,333
5,751,594
Income (loss) from operations
1,187,599
(1,765,024)
Other income (expense)
Other income (expense)
6,290
(50,622)
Interest income
10,767
39,526
Interest expense
(117,127)
(104,983)
Total other expense
(100,070)
(116,079)
Income (loss) before income taxes
1,087,529
(1,881,103)
Provision for income taxes
(268)
(38,878)
Net Income (loss)
1,087,797
(1,842,225)
Other comprehensive income (loss)
Foreign currency translation gain
3,009,424
4,741,241
Comprehensive income
$ 4,097,221
$ 2,899,016
Basic weighted average shares outstanding (in Shares)
15,770,934
14,793,538
Basic net income (loss) per share (in Dollars per share)
$ 0.07
$ (0.12)
Diluted weighted average shares outstanding (in Shares)
15,770,934
14,793,538
Diluted net income (loss) per share (in Dollars per share)
$ 0.07
$ (0.12)
Jinong
Sales
Net sales
$ 6,796,657
$ 7,421,658
Cost of goods sold
Cost of goods sold
4,340,170
4,728,887
Gufeng
Sales
Net sales
5,213,257
7,439,542
Cost of goods sold
Cost of goods sold
4,588,338
6,507,133
Yuxing
Sales
Net sales
2,450,597
2,340,444
Cost of goods sold
Cost of goods sold
2,076,071
1,940,638
Antaeus
Sales
Net sales
163,295
Cost of goods sold
Cost of goods sold
$ 201,711
v3.25.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities
Net income (loss)
$ 1,087,797
$ (1,842,225)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization
548,827
710,403
Provision for losses on accounts receivable
290,179
632,074
Inventories impairment
107,882
2,038,575
Change in fair value of Bitcoin
262
Changes in operating assets
Digital assets
42,206
Accounts receivable
(1,497,030)
(5,759,561)
Other current assets
(460,379)
55,875
Inventories
(777,538)
1,716,380
Advances to suppliers
3,774,885
(3,335,723)
Other assets
1,366
470,581
Deferred tax assets
(268)
(38,878)
Changes in operating liabilities
Accounts payable
(217,950)
(105,889)
Customer deposits
(1,106,858)
2,160,214
Amount due to related parties
21,516
86,979
Tax payables
(44,627)
6,920
Accrued expenses and other payables
(3,047,493)
607,896
Interest payable
1,499
Net cash used in operating activities
(1,318,192)
(2,553,911)
Cash flows from investing activities
Purchase of plant, property, and equipment
(12,952)
(48,239)
Long-term equity investment
(8,495,862)
Net cash used in investing activities
(12,952)
(8,544,101)
Cash flows from financing activities
Proceeds from loans
5,726,880
Repayment of loans
(511,362)
(3,743,424)
Repurchases of common stock
(1,216)
Net cash (used in) provided by financing activities
(512,578)
1,983,456
Effect of exchange rate change on cash and cash equivalents
2,577,421
1,819,541
Net increase (decrease) in cash and cash equivalents
733,699
(7,295,015)
Cash and cash equivalents, beginning balance
52,519,418
58,772,587
Cash and cash equivalents, ending balance
53,253,117
51,477,572
Supplement disclosure of cash flow information
Interest expense paid
115,628
104,983
Income taxes paid
$ 53,210
$ 66,407
v3.25.3
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Jun. 30, 2025
Current assets
Cash and cash equivalents
$ 53,253,117
$ 52,519,418
Accounts receivable, net
20,678,903
19,345,061
Inventories, net
37,878,957
36,975,287
Advances to suppliers, net
8,649,281
12,367,419
Other current assets
10,855,715
10,395,335
Total current assets
131,315,973
131,602,520
Non-current assets
Plant, property and equipment, net
11,819,207
12,224,583
Intangible assets, net
13,305,067
13,279,462
Other non-current assets
589,578
590,483
Total non-current assets
25,713,852
26,094,528
Total assets
157,029,825
157,697,048
Current liabilities
Accounts payable
1,526,269
1,736,031
Customer deposits
3,441,483
4,526,024
Accrued expenses and other payables
19,288,885
22,289,890
Taxes payable
26,468,505
26,528,836
Short term loans
9,562,517
4,720,934
Total current liabilities
66,201,594
65,687,751
Long-term loans
2,612,556
7,889,627
Total non-current liabilities
2,612,556
7,889,627
Total liabilities
68,814,150
73,577,378
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $.001 par value, 20,000,000 shares authorized, 0 shares issued and outstanding as of September 30, 2025 and June 30, 2025, respectively
Common stock, $.001 par value, 115,197,165 shares authorized, 16,116,914 and 16,116,914 shares issued, respectively; 15,769,434 and 15,770,934 shares outstanding as of September 30, 2025 and June 30, 2025, respectively
16,117
16,117
Additional paid-in capital
246,306,702
246,306,702
Statutory reserve
26,906,554
26,787,507
Retained earnings
(159,611,840)
(160,580,590)
Less: Treasury Stock
(399,742)
(398,526)
Accumulated other comprehensive loss
(25,002,116)
(28,011,540)
Total Stockholders’ Equity
88,215,675
84,119,670
Total Liabilities and Stockholders’ Equity
157,029,825
157,697,048
Related party
Current liabilities
Amount due to related parties
$ 5,913,935
$ 5,886,036